Gerber J G, Hubbard W C, Branch R A, Nies A S
Prostaglandins. 1978 Apr;15(4):663-70. doi: 10.1016/0090-6980(78)90063-1.
We determined the effect of 2 mg/kg intravenous furosemide on the production and metabolism of prostaglandin E2 in the utero-placental unit of pregnant dogs. Uterine venous prostaglandins E2 and 15-keto-13,14-dihydro E2 were measured by gas chromatography-mass spectrometry. Even though the dose of furosemide was adequate to effect a good diuresis, neither the production nor the metabolism of prostaglandin E2 by the uterus was altered by that dose of the drug. Using radioactive microspheres to measure hemodynamic parameters, we observed no change in uterine vascular resistance while renal vascular resistance decreased. Although the renal concentration of furosemide may be higher than the uteroplacental concentration, there is so far no evidence in vivo that usual doses of furosemide enhance the production or inhibit the metabolism of prostaglandin E2.
我们测定了2毫克/千克静脉注射速尿对妊娠犬子宫胎盘单位中前列腺素E2生成和代谢的影响。通过气相色谱 - 质谱法测定子宫静脉中的前列腺素E2和15 - 酮 - 13,14 - 二氢E2。尽管速尿的剂量足以产生良好的利尿作用,但该剂量的药物既未改变子宫对前列腺素E2的生成,也未改变其代谢。使用放射性微球测量血流动力学参数,我们观察到子宫血管阻力没有变化,而肾血管阻力降低。虽然速尿在肾脏中的浓度可能高于子宫胎盘的浓度,但迄今为止尚无体内证据表明常规剂量的速尿会增强前列腺素E2的生成或抑制其代谢。